admission date:  [2195-12-24]              discharge date:   [2196-1-2]date of birth:  [2128-11-8]             sex:   mservice: medicineallergies:patient recorded as having no known allergies to drugsattending:[first name3 (lf) 1055]chief complaint:nausea/vomiting, abdominal pain. transferred from osh.major surgical or invasive procedure:ercp with stent placed in cbd [2195-12-24]endotracheal intubation [2195-12-24]; extubated [2195-12-29]history of present illness:67 yo male, h/o 3vd, [month/day/year ] s/p ablation in [4-27] at [hospital1 2025], ra,diastolic dysfunction, who presented from [hospital 1263] hospital with?biliary sepsis.  pt reports that on day of admission, he wokeup with malaise, nausea, vomiting, fevers, and rigors.  he wentto [doctor last name 1263] ed, found to be febrile with abnormal lft's, wasstarted on antibiotics  (clinda/ceftaz) and ivf, and wastransferred to [hospital1 18] for presumed biliary sepsis and furthermanagement.  on transfer, he was started on zosyn/levo/flagyl,was hemodynamically unstable, was intubated prior to ercp.  ercpshowed no obstruction, no stones, some biliary sludging only(normal cholangiogram).  a stent was placed in the cbd.  hecontinued to by hypotensive/unstable post ercp, was found tohave an evolving nstemi (tnt leak, 2mm st depre in v3-v6; peaktnt 1.8, now trended down).  he remained intubated.  swan on[12-24] showed pcwp 35, bp 95/43, fa=22, and the next warning, hewent into rapid afib with decompensation requiring single 200 jshock.  he was on 3 pressors at the time (levophed, vasopressin,dopa), converted into nsr temporarily, was started on amio. hehad recurrence of afib.  dccv was repeated 2 times withoutsuccess; he spontaneously reverted to nsr (?s/p dccv on [12-26])has remained in this rhythm, and is on an amio taper (drip).cardiology is following.  etiology of this new onset afib wasthought to be in the setting of volume resuscitation and acuteillness.with respect to his sepsis, he required 3 pressors as above, wason vanco/zosyn/lev/flagyl.  blood cultures from [doctor last name 1263] grew out[4-26] e. coli (with e. coli also in urine) resistant toamp/pip/sulbactam.  ciprofloxacin was added to regimen on [12-26].he is currently just on cipro and is to complete a 14 day coursefor e. coli.  he continued to improve clinically, was extubatedon [12-29], and he was transferred to the floor on [12-30] (stable,mentating).  other micu events include a drop in plateletsfollowing 48 hours of heparin therapy (hit negative, hep d/c'ed,and platelets recovering).  he had a bump in his creatinine to3.0 (baseline 1.3-1.5 as per pcp) which is resolving (?atn [2-23]hypotension but no muddy brown casts on sediment).  renal us wasobtained that did not show hydronephrosis or cause or arf.  hcthas been stable, but he has been guaiac positive on exam.  ptwas stable on transfer to the floor.past medical history:cardiac:1.  severe 3vd by report; apparently not a surgical candidate.cardiologist is dr. [first name8 (namepattern2) 59998] [last name (namepattern1) ] at [hospital1 2025], recent p-mibi on [5-26]2. history of [month/year (2) ]/svt, s/p ablation in [5-26]3.  mi [6-29] yrs ago; few episodes of angina since that timeother pmh:1.  ra x 30 yrs, on remicaide and mtx, symptoms stable; usuallyhas sx in shoulders and knees; rheum: dr. [first name (stitle) ] [name (stitle) ] in [hospital1 392]2.  ?h/o hbv3.  gerd4.  pilonidal cyst in 20'smeds on transfer:ciprofloxacin 500 [hospital1 ] (d4/14; d1=[12-26])amiodarone taperoxybutynin 5 mg tidssiasa 325lansoprazoleativan prnmso4 prnnystatin suspensionall: nkdasocial history:quit smoking 30 yrs ago; smoked [1-23] ppd prior to thissocial etohno drugs/ivdu everhomosexual, lives with partner; had neg hiv test 3 yrs ago, hasbeen monogamous with his partner since that timefamily history:mother died lung ca age 76 (smoker)uncle-cabgphysical exam:vs: 98.4    57    129/62    15   98% ra     wt=132 kg; admission118.7 kggen: very pleasant male, nad, sitting in bed, comfortable, a&ox3heent: perrl, eom grossly intact, op clearneck: no jvd appreciated, no lad, no bruitscv: rrr, nl s1/s2, no m/r/glungs: cta b from anterior exam, no w/r/rabd: soft, nt/nd, nabsextr: [2-24]+ edema in ue and le (with pneumoboots on ue/le); stillwith foley and rectal tubepertinent results:[2195-12-24] 10:10pm   hgb-12.7 calchct-38 o2 sat-77[2195-12-24] 10:09pm   type-art temp-37.6 po2-195 pco2-36 ph-7.28total co2-18 base[2195-12-24] 10:09pm   o2 sat-98[2195-12-24] 07:27pm   lactate-3.3[2195-12-24] 05:03pm   freeca-1.11[2195-12-24] 04:50pm   glucose-130 urea n-34 creat-2.6 sodium-140potassium-4.8 chloride-109 total co2-16 anion gap-20[2195-12-24] 04:50pm   ck-mb-49 mb indx-7.7 ctropnt-0.51[2195-12-24] 03:18am   fibrinoge-654[2195-12-24] 03:18am   alt(sgpt)-181 ast(sgot)-191 ck(cpk)-405alk phos-175 amylase-55 tot bili-4.5 dir bili-3.8 indirbil-0.7[2195-12-24] 03:18am   lipase-13[2195-12-24] 03:18am   albumin-3.1 calcium-7.5 phosphate-3.1magnesium-1.0[2195-12-24] 03:18am   hbsag-negative hbs ab-positive havab-negative[2195-12-24] 03:18am   hcv ab-negative[2195-12-24] 03:18am   wbc-33.7 rbc-4.30 hgb-14.2 hct-42.0 mcv-98mch-33.0 mchc-33.8 rdw-15.4[2195-12-24] 03:18am   neuts-78 bands-6 lymphs-3 monos-11 eos-0basos-0 atyps-0 metas-2 myelos-0[2195-12-24] 03:18am   hypochrom-normal anisocyt-1+ poikilocy-normalmacrocyt-1+ microcyt-normal polychrom-normal[2195-12-24] 03:18am   plt count-250[2195-12-29] 3:59 pmportable renal ultrasound: limited views of both kidneys wereobtained. the right kidney measures 11.7 cm. the left kidneymeasures 11.2 cm. there is no evidence of renal stones,hydronephrosis, or perinephric fluid collections.impression:limited portable exam shows no significant abnormalities.chest (portable ap)  [2195-12-24] 3:21 aman ap portable study of the chest was obtained. no prior studiesavailable for comparison. there is poor inspiratory effort. thelungs are clear of an active congestion or infiltration. noevidence of pleural effusion or pneumothoraces. the cardiac sizecannot be evaluated on this ap portable study of the chest. aleft subclavian cvp line is in place the tip is entering thesuperior vena cava.impression: no evidence of active diseases in the lungs orheart.abdomen (supine only) port  [2195-12-24] 6:44 pm: there are multiplemildly gas distended loops of small bowel and gas present in thecolon. a plastic biliary stent is present in the right upperquadrant. the diaphragms are not included on the film.impression: mildly gas distended loops of small bowel,nonspecific.liver or gallbladder us (single organ) port  [2195-12-24] 3:53 am:findings: examination is limited due to patient body habitus.allowing for this, liver appears echogenic, consistent withfatty infiltration. no focal masses are identified. there is nointrahepatic or extrahepatic ductal dilatation. the common bileduct measures 6 mm in diameter. the gallbladder contains sludge,but there are no secondary signs of cholecystitis. specifically,there is no wall edema, pericholecystic fluid, or gallbladderdistention. normal color flow is identified within the mainportal and hepatic veins. there is no ascites. note is made of amarkedly atrophic right kidney, with evidence of corticalthinning.impression:1) echogenic liver consistent with fatty infiltration. pleasenote that more severe forms of liver disease, includingsignificant hepatic fibrosis and cirrhosis, cannot be excludedon the basis of this study.2) gallbladder sludge but no secondary signs of cholecystitis.3) no evidence of biliary obstruction.4) patent portal and hepatic veins[2195-12-24] ecg: sinus rhythm premature ventricular contractionsinferior/lateral st-t changes are nonspecificsince pervious tracing, no significant changeintervals: rate 93 pr 148 qrs 86  qt/qtc 378/428 axis: p 43 qrs0 t -16read by: [last name (lf) 2889],[first name3 (lf) 2890] k.cardiology report echo study date of [2195-12-25]patient/test information:indication: left ventricular function. myocardial infarction.height: (in) 68weight (lb): 300bsa (m2): 2.43 m2bp (mm hg): 74/60hr (bpm): 66status: inpatientdate/time: [2195-12-25] at 10:55test: portable tte (complete)doppler: full doppler and color dopplercontrast: nonetape number: 2004w487-1:24test location: west micutechnical quality: suboptimalreferring doctor: dr. [first name11 (name pattern1) ] [initial (namepattern1) ] [last name (namepattern4) ]measurements:left atrium - long axis dimension: 4.8 cm (nl <= 4.0 cm)left atrium - four chamber length: 5.8 cm (nl <= 5.2 cm)right atrium - four chamber length: 5.0 cm (nl <= 5.0 cm)left ventricle - septal wall thickness: 1.2 cm (nl 0.6 - 1.1cm)left ventricle - inferolateral thickness: 0.9 cm (nl 0.6 - 1.1cm)left ventricle - diastolic dimension: 5.7 cm (nl <= 5.6 cm)left ventricle - ejection fraction: <= 25% (nl >=55%)aorta - valve level: 3.6 cm (nl <= 3.6 cm)aorta - ascending: 3.5 cm (nl <= 3.4 cm)aortic valve - peak velocity: 1.0 m/sec (nl <= 2.0 m/sec)mitral valve - e wave: 0.7 m/secmitral valve - e wave deceleration time: 148 msectr gradient (+ ra = pasp): 25 to 30 mm hg (nl <= 25 mm hg)interpretation:findings:left atrium: mild la enlargement.right atrium/interatrial septum: normal ra size. a catheter orpacing wire isseen in the ra and/or rv.left ventricle: mildly dilated lv cavity. severe global lvhypokinesis.severely depressed lvef.right ventricle: rv not well seen.aorta: normal aortic root diameter.aortic valve: mildly thickened aortic valve leaflets (3). no ar.mitral valve: mildly thickened mitral valve leaflets. mild (1+)mr.tricuspid valve: normal tricuspid valve leaflets with trivialtr.pericardium: no pericardial effusion.general comments: suboptimal image quality - poor echo windows.conclusions:1. the left atrium is mildly dilated.2. the left ventricular cavity is mildly dilated. there issevere global leftventricular hypokinesis. overall left ventricular systolicfunction isdifficult to assess but is probably severely depressed.3. the aortic valve leaflets (3) are mildly thickened.4. the mitral valve leaflets are mildly thickened. mild (1+)mitralregurgitation is seen.electronically signed by [first name8 (namepattern2) ] [last name (namepattern1) 1445], md on [2195-12-25] 11:19.date: thursday, [2195-12-24] endoscopist(s): [name6 (md) ] [name8 (md) ],md[first name (titles) ] [last name (titles) 59820], md (fellow)patient: [known firstname ] [known lastname ] ref.phys.: [first name8 (namepattern2) ] [last name (namepattern1) ], mdbirth date: [2128-11-8] (67 years) instrument: tjf 160id#: [numeric identifier 59999] asa class: p2medications: general anesthesiaindications: 67 y o male with nausea, vomiting, epigastric pain,elevated lft and hypotension. ercp to evaluate for biliaryobstruction. level 3 consult was performed.procedure: the procedure, indications, preparation and potentialcomplications were explained to the patient, who indicated hisunderstanding and signed the corresponding consent forms. thepatient was placed in the prone position and an endoscope wasintroduced through the mouth and advanced under directvisualization until the second part of the duodenum was reached.careful visualization was performed. the procedure was notdifficult. the quality of the preparation was good. the patienttolerated the procedure well. there were no complications.findings: esophagus: limited exam of the esophagus was normalstomach: limited exam of the stomach was normalduodenum: limited exam of the duodenum was normalmajor papilla: major papilla was located inside a diverticulum.cannulation:  cannulation of the biliary duct was successful anddeep with a sphincterotome using a free-hand technique. contrastmedium was injected resulting in complete opacification. theprocedure was not difficult. an additional cannulation attemptof the biliary duct was successful and superficial with asphincterotome using a free-hand technique. contrast medium wasinjected resulting in partial opacification. the procedure wasnot difficult.biliary tree: normal cholangiogram without biliary obstruction.small stone in cbd can't be ruled out.  opacified portion ofpancreatic duct in the head was normal.procedures: a 9 cm by 10 fr cotton-[doctor last name ] biliary stent wasplaced successfully in the cbd .impression: 1. major papilla was located inside a diverticulum.2. normal cholangiogram without biliary obstruction. small stonein cbd can't be ruled out.3. given sepsis of unclear source and the fact that a smallstone could not be ruled out, a  9 cm by 10 fr cotton-[doctor last name ]biliary stent was placed successfully in the cbd.4. opacified portion of pancreatic duct in the head was normal.additional notes: the procedure was performed by dr. [last name (stitle) ](attending physician) and ercp fellow.brief hospital course:a/p: 67 yo male, h/o severe 3vd, ra, presenting from osh with?biliary sepsis, s/p ercp with stent placed, being treated forurosepsis vs biliary sepsis, extubated and doing well.1. sepsis: the patient's initial picture was consistent withseptic + cardiogenic shock. initial sg numbers revealed highsvr, low co, and high pcwp. he remained hypotensive despite ivf,and pressors were continued, with eventual triple pressortherapy (levo, dopamine and vasopressin) required forhemodynamic support. a random cortisol was 20, and 29post-cosyntropin. despite appropriate response, the low randomcortisol prompted initiation of steroid therapy, initiallydexamethasone, then hydrocortisone and fludrocortisone with planto complete 7 days of rx (completed). his lactate, elevated onadmission, came down. he was successfully weaned off levo andvasopressin on [2195-12-28], then off dopamine on [2195-12-29]. ercp didnot show obstruction, ?biliary sludge.  he was initially onvanco/zosyn/flagyl-->cipro/vanco/flagyl.  vanco/flagyl werediscontinued on [12-27] (c. diff neg x 3), and he will continue acourse of cipro for ?urosepsis.  all cultures here have beenngtd, but he is being treated for [4-26] e. coli blood culturebottles at [doctor last name 1263].  ciprofloxacin was continued for the 14 daycourse (until [1-9]).  he was hemodynamically stable throughouthospitalization.  blood pressure medications were initially held[2-23] hypotension.  lisinopril was restarted prior to dischargeafter renal function improved.  atenolol was held given patientwas still on amiodarone taper.  this should be restarted afterhe follows up with his pcp/cardiologist.2. nstemi: the [hospital 228] hospital course was complicated bytroponin elevation felt secondary to demand in the setting ofacute illness (peak troponin 1.86). he received 48 hours ofintravenous heparin, d/c'd in the setting of thrombocytopenia.an echo was performed on [12-25], which revealed severe global lvhypokinesis with ef<25%. cardiology followed in-house.lisinopril, asa, were continued. lipitor was added upondischarge at a lower dose, and atenolol was held.  this shouldbe restarted when amiodarone taper is completed and he followsup with his primary cardiologist.  he also had an echo in-houseshowing a very depressed ef (<25%), likely [2-23] myocardialsuppression from sepsis.  he should have a follow up tte afterdischarge from rehab.3. afib: patient went into atrial fibrillation on [12-25] with rvrand hypotension. cardioversion was attempted without success. hewas loaded with amiodarone iv and an amiodarone drip wasinitiated. he converted to nsr in pm. then, he reverted backinto afib on [12-26] after an increase in dopamine dose to 3(?true-true and unrelated?). given low cardiac output andongoing hypotension requiring 3 pressors, cardioversion wasperformed with conversion to nsr after a single 200j shock. thepatient was switched to po amiodarone on [12-26], to be continuedtid until [1-2], then [hospital1 ] for 1 week, then qd for 1 week, then200 mg po qd until cardiology follow-up. he remained in nsrthroughout hospitalization after transfer out of the unit.  hisatenolol was held and should be restarted after he finishes hisamiodarone taper and follows up with his cardiologist, dr.[last name (stitle) ].  he was started on fondaparinux/coumadin foranticoagulation (afib and low ef).  goal inr is [2-24],fondaparinux can be d/c'ed when inr=1.8.4. arf on crf: per patient's pcp (dr. [last name (stitle) ], baselinecreatinine around 1.3-1.5. peak creatinine 3.0 at osh. mr. [known lastname ]was initially oliguric on admission. his urine output slowlyimproved with better hemodynamics, with slowly improvingcreatinine. urine lytes suggestive of renal etiology (likely atn[2-23] hypotension from sepsi), and urine sediment bland. currently2.1, and auto-diuresing and mobilising fluid. rus withoutevidence of hydronephrosis or other abnormality.  his creatininereturned to baseline (1.3) and was stable on discharge.  hediuresed very well on iv lasix (goal 2l/d).  he was discharge onpo bumex 1 mg daily.  this should be continued until he isclinically euvolemic and his peripheral edema is resolved.5. transaminitis: s/p ercp with stent placement, but onlyfinding of sludge. query transaminitis in setting of sepsis.lft's were back to normal at time of discharge.  they should bechecked within a week of discharge.  lipitor was restarted atlower dose upon discharge and can be titrated up.7. thrombocytopenia: while in icu, platelets were noted to dropto a nadir in the 80s. concern for hit was raised and heparinwas discontinued after 48 hours of therapy. hit screen negative.picture no c/w dic. ultimately, thrombocytopenia was feltmedication-induced, query direct effect of heparin versusantibiotics (vanco, flagyl). now slowly rising.  this was likleymultifactorial in the setting of sepsis, medications, pressorsand not [2-23] heparin.  platelets continued to go up and werestable at time of discharge.8.  ?glucose intolerance: continue on ssi, no history of dm,likely in setting of steroids for sepsis.  ssi should becontinued as long as pt has abnormal blood sugars.  if thisintolerance persists, pcp should recommend further therapy.9.  code: full10.  dispo: patient was seen by physical therapy in house andwas thought to require acute level rehabilitation fordeconditioning. he was discharged to [hospital1 ] rehabiliation forphysical therapy and diuresis.medications on admission:aspirin 325 po dailylipitor 80 dailyprotonix 40 dailyfolate 1 mg po dailyzestril 10 po dailyatenolol 25 dailyremicaid q weeksdischarge medications:1. aspirin 325 mg tablet sig: one (1) tablet po daily (daily).2. nystatin 100,000 unit/ml suspension sig: five (5) ml po qid(4 times a day) as needed.3. insulin regular human 100 unit/ml solution sig: sliding scale injection asdir (as directed): for bs 150-200, give 2 u, for bs201-250, give 4 u, for bs 251-300, give 6u, for bs 301-350, give8u, for bs 351-400, give 10 u.4. oxybutynin chloride 5 mg tablet sig: one (1) tablet po tid (3times a day) as needed.5. ciprofloxacin 500 mg tablet sig: one (1) tablet po q12h(every 12 hours) for 7 days: continue until [1-9].6. amiodarone hcl 200 mg tablet sig: two (2) tablet po bid (2times a day) for 7 days: continue [date range (1) 60000].7. amiodarone hcl 200 mg tablet sig: two (2) tablet po daily(daily): continue until you follow up with cardiology.8. pantoprazole sodium 40 mg tablet, delayed release (e.c.) sig:one (1) tablet, delayed release (e.c.) po q24h (every 24 hours).9. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times aday) as needed.10. zolpidem tartrate 5 mg tablet sig: two (2) tablet po hs (atbedtime) as needed.11. fondaparinux sodium 2.5 mg/0.5 ml syringe sig: one (1)subcutaneous daily (daily): continue until therapeutic oncoumadin.  overlap therapy for 2 days with therapeutic coumadindosing.12. morphine sulfate 2-4 mg iv q4h:prn13. lorazepam 0.5-2 mg iv q4h:prn14. warfarin sodium 2 mg tablet sig: one (1) tablet po hs (atbedtime): please ck inr every other day for goal inr [2-24].adjust coumadin dosing accordingly.15. lisinopril 2.5 mg tablet sig: one (1) tablet po once a day.16. bumex 1 mg tablet sig: one (1) tablet po once a day.17. lipitor 40 mg tablet sig: one (1) tablet po once a day.18. cyanocobalamin 1,000 mcg tablet sustained release sig: one(1) tablet sustained release po once a day.discharge disposition:extended carefacility:[hospital3 7] & rehab center - [hospital1 8]discharge diagnosis:primary diagnoses1.  sepsis2.  biliary stenting (ercp), ?biliary sepsis3.  respiratory failuresecondary diagnoses1.  new onset atrial fibrillation in setting of illness2.  nstemi in setting of acute illness3.  acute renal failure/atn4.  thrombocytopenia5.  3 vessel coronary artery disease6.  chf with diastolic dysfunctiondischarge condition:stable--afebrile, all blood cultures negative, breathingcomfortably on room air, requires further diuresis and physicaltherapy.discharge instructions:1.  please take all your medications as described in thedischarge instructions.  we made a few changes to yourmedication regimen.-we added bumex 1 mg po qam, for diuresis.  goal is 2l neg/dayuntil you are clinically euvolemic, peripheral edema isresolved.- you should finish a course of antibiotics (ciprofloxacin);continue until [1-9], for positive blood cultures- you can continue the oxybutynin for bladder spasms if youcontinue to requires this- we started you on fondaparinux and coumadin (anticoagulationfor your atrial fibrillation and low ejection fraction).  thefondaparinux will only be continued until you are therapeutic onyour coumadin.- you should finish amiodarone taper as outlined in medicationssection.- we are holding your beta blocker (you were on atenolol 25 mgdaily) for now until you complete the amiodarone taper andfollow up with your cardiologist.- we are also holding your rheumatoid arthritis medications atthis time (mtx, remicaide).  these should be restarted after youleave rehab and follow up with your primary rheumatologist.- we also decreased your lipitor to 40 qd.  you should increasethis after having your lft's rechecked by your pcp.2.  follow up with your pcp, [last name (namepattern4) ]. [last name (stitle) ], within 1 week ofleaving rehab.  he may want to make adjustments to yourmedication regimen at this time.  you should also follow up withthe cardiology clinic here and your rheumatologist upon leavingrehab.3.  call your physician if you experience chest pain, shortnessof breath, fevers > 101. take your medications as prescribed.weigh yourself daily and record your weight. call your physicianif your weight increases by 3 lbs.followup instructions:1.  follow up with your pcp, [last name (namepattern4) ]. [last name (stitle) ] ([telephone/fax (1) 60001]), within1 week of leaving rehab.  he may want to make adjustments toyour medication regimen at this time.  he can consider stoppingyour bumex at this time, restart your beta blocker and yourrheumatoid arthritis medications.2.  you should also follow up with your cardiologist, dr. [first name8 (namepattern2) 59998][last name (namepattern1) ], at [hospital1 2025].  you will be on an amiodarone taper until thistime.  she should consider restarting your atenolol at this timeand monitor your coumadin therapy.  she should also considertitrating up your lisinopril to your usual dose (10 mg daily) atthis time.  we are discharging you on 2.5 mg daily.3.  follow up with liver clinic, dr. [first name (stitle) ] [name (stitle) ] ([telephone/fax (1) 60002]), in 2 months for removal of your biliary stent.  callto make this appointment as soon as possible3.  follow up with your rheumatologist upon leaving rehab.  shemay decide when to restart your methotrexate and remicaidebring this discharge paperwork with you at time of all follow upappointments